Hopital Roger Salengro

Running trials

• Recruiting

  Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod

  NCT07072988· Phase 4· Source

• Recruiting

  Predictive Value of the Optic Nerve Involvement in Clinically Isolated Syndrome

  NCT06455332· Source

• Enrolling by invitation

  A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)

  NCT06908226· Phase 3· Source

• Active, not recruiting

  A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)

  NCT06719141· Phase 3· Source

• Active, not recruiting

  A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)

  NCT06660394· Phase 3· Source

• Recruiting

  TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France)

  NCT06924099· Source

• Recruiting

  Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD

  NCT05566769· Source

• Active, not recruiting

  MS-DETECT: Early Detection of Multiple Sclerosis Progression With MSCopilot® Detect

  NCT05816122· Source

• Recruiting

  Safety, Performance and Usability of BALT Medical Devices: The EVIDENCE Post Marketing Clinical Follow-up Platform

  NCT04927156· Source

• Recruiting

  Effect of CAFfeine on Cognition in Alzheimer's Disease

  NCT04570085· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease1 recruiting
• Epilepsy1 recruiting
• Glioblastoma1 recruiting
• Multiple sclerosis1 recruiting
• Myasthenia gravis1 recruiting
• Neuromyelitis optica (NMOSD)1 recruiting
• Stroke1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Prospective Observational Study of Filgotinib in Participants With Rheumatoid Arthritis in France

  NCT05323591· Source

• Terminated

  A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome

  NCT05163314· Phase 3· Source

• Completed

  A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome

  NCT04938427· Phase 3· Source

• Completed

  A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease

  NCT04592874· Phase 2· Source